International Assets Investment Management LLC Has $1.07 Million Holdings in MetLife, Inc. $MET

Key Points

• International Assets Investment Management LLC significantly reduced its stake in MetLife, Inc. by 87.1%, owning 13,316 shares worth approximately $1.07 million as of its latest SEC filing.
• MetLife's recent earnings report revealed an EPS of $2.02, missing estimates by $0.30, with quarterly revenue declining 2.7% year-over-year.
• The company announced a quarterly dividend of $0.5675 per share, equating to a 2.9% yield, with the ex-dividend date set for November 4th.

International Assets Investment Management LLC lowered its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 87.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,316 shares of the financial services provider's stock after selling 89,921 shares during the quarter. International Assets Investment Management LLC's holdings in MetLife were worth $1,071,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in MET. North Capital Inc. acquired a new stake in shares of MetLife during the first quarter valued at approximately $26,000. Motco raised its holdings in shares of MetLife by 105.5% during the first quarter. Motco now owns 413 shares of the financial services provider's stock valued at $33,000 after acquiring an additional 212 shares during the period. GFG Capital LLC acquired a new stake in shares of MetLife during the second quarter valued at approximately $38,000. Abound Wealth Management raised its holdings in shares of MetLife by 652.3% during the second quarter. Abound Wealth Management now owns 489 shares of the financial services provider's stock valued at $39,000 after acquiring an additional 424 shares during the period. Finally, Legend Financial Advisors Inc. acquired a new position in MetLife in the 2nd quarter valued at approximately $40,000. Institutional investors and hedge funds own 94.99% of the company's stock.

MetLife Stock Performance

Shares of MET opened at $78.55 on Monday. The company's fifty day moving average is $80.20 and its 200-day moving average is $78.10. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05. The firm has a market cap of $52.24 billion, a price-to-earnings ratio of 13.31, a price-to-earnings-growth ratio of 0.71 and a beta of 0.86. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57.

MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing the consensus estimate of $2.32 by ($0.30). MetLife had a return on equity of 19.88% and a net margin of 5.83%.The business had revenue of $17.34 billion for the quarter, compared to analyst estimates of $18.58 billion. During the same quarter last year, the company earned $2.28 EPS. The business's revenue for the quarter was down 2.7% compared to the same quarter last year. Equities analysts expect that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th will be issued a dividend of $0.5675 per share. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Tuesday, November 4th. MetLife's dividend payout ratio is currently 38.47%.

Wall Street Analysts Forecast Growth

MET has been the topic of several research reports. Barclays upped their price objective on shares of MetLife from $93.00 to $98.00 and gave the company an "overweight" rating in a research note on Wednesday, October 8th. Wolfe Research upgraded shares of MetLife to a "strong-buy" rating in a research note on Tuesday, September 16th. Weiss Ratings reiterated a "buy (b)" rating on shares of MetLife in a research note on Wednesday, October 8th. UBS Group dropped their price objective on shares of MetLife from $94.00 to $91.00 and set a "buy" rating on the stock in a research note on Thursday, August 7th. Finally, Jefferies Financial Group upped their price objective on shares of MetLife from $100.00 to $103.00 and gave the company a "buy" rating in a research note on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $95.18.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.